U.K. Backs Three-Person IVF

The United Kingdom is drawing up draft guidelines for mitochondrial transfer procedures to prevent mothers passing on diseases to their children.

Written byDan Cossins
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, VOICEBOKSThe United Kingdom has moved a step closer to becoming the first country to approve a new type of in vitro fertilization that creates babies with DNA from three parents. By transferring the nuclear DNA from the sperm and egg of prospective parents into an enucleated egg donated by a person with healthy mitochondria, the procedures could prevent mothers from passing mitochondrial diseases onto their children.

After a public consultation revealed broad support for the technique, the UK’s Department of Health last week (June 27) announced that draft regulation for fertility clinics wishing to perform the procedure will be ready by this fall. Parliament will then vote on the guidelines at some point next year.

Opponents of the plans are concerned that the move sets the UK on a slippery slope toward designer babies and other forms of genetic modification of humans. But while acknowledging the existence of “sensitive issues,” Dame Sally Davis, England’s chief medical officer, said she was “personally very comfortable” about pushing on with procedures that prevent disease by replacing mitochondria. “It’s only right that we look to introduce this life-saving treatment as soon as we can,” said ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs

Products

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform

nuclera logo

Nuclera eProtein Discovery System installed at leading Universities in Taiwan

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control